[{"Assets_0_Q1_USD":"1093308000.0","CIK":"1743881","CommonStockSharesIssued_0_Q1_shares":"152289274.0","CommonStockSharesOutstanding_0_Q1_shares":"149114600.0","Country":"United States","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1594164456.0","MinorityInterest_0_Q1_USD":"5929000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-150765000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":"-163079000.0","OfficialName":"BridgeBio Pharma Inc. Common Stock","ProfitLoss_1_Q1_USD":"-171082000.0","RevenuesConverted_1_Q1_USD":"462000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"-389365000.0","StockholdersEquity_0_Q1_USD":"-395294000.0","Ticker":"BBIO","TreasuryStockSharesConverted_0_Q1_shares":"3174674.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":"138627729.0","filed":"20210506","footnote":null,"form":"10-Q","fp":"Q1","fy":"2021.0","name":"BRIDGEBIO PHARMA, INC.","period":"20210331","qtrs":"0","uom":"USD"}]